¬Ì±¡¦nÂà ¤´»ÝÀ¹¤f¸nÁפHÀ½
¦U¬Ù¬ÛÄ~©ñ¼e¨¾¬Ì±¹¬I ÃÓµú¸Ö®£ÀH«á¯f¨Ò¿E¼W

[2022.02.19] µoªí
°¾°ª±µºØ²v¬O¥[°êªº§Ü¬ÌÀu¶Õ¡C(¬üÁpªÀ)

¡i©ú³ø±M°T¡jÁp¨¹­º®uÂåÀøºÞÃÓµú¸ÖÂå¥Íªí¥Ü¡A¥ÑOmicron¤Þµoªº¬Ì¼é¡A¥Ø«e¤w¸g¹L¤F°ª®p´Á¡A¦ý¦U¬Ù©ñ¼e¨¾¬Ì±¹¬Iªº°µªk¡A«Ü¥i¯à·|¾É­P¬Ì±¡±²¤g­«¨Ó¡C¹w´ú¼Ò«¬Åã¥Ü¡A©Ò¦³©ñ¼e­­¨î±¹¬Iªº¬Ù¥÷¡A³£¥i¯à·|¥X²{¯f¨Ò¿E¼Wªºª¬ªp¡C

ÃÓµú¸ÖÂå¥Í¬Q(18¤é)¤½¥¬ªº¹w´ú¼Ò«¬Åã¥Ü¡A³q¹LºÊ´ú¦Ã¤ô¤ºªº¯f¬r§t¶q¡AÅã¥Ü³o¤@ªi¬Ì¼é¥¿°h«o¡A¦ýOmicronªº¯u¹ê·P¬V¤H¼Æ¡AÁÙ¬O»·°ª©ó¤½¥¬¥X¨Óªº¤H¼Æ¡C

ÁöµM³o¬O¤@­Ó¨}¦nªºÁͶաA¦ý¯f¬r¤´µM¦b°ª³t¶Ç¼½¡AÂå°|ªº¸ê·½¨Ì®»Ą̃£¨y¡C¬°¦¹¤j®a¤]¤´»ÝÄ~Äò±Ä¨ú¹w¨¾±¹¬I¡A¥]¬AÁ׶}¾ÖÀ½ªº¦a¤è¡A¥²­n®ÉÀ¹¤f¸n¡C

¦P®É¡A¹ï©ó¦U¬Ù¯É¯É©ñ¼e¨¾¬Ì±¹¬Iªº°µªk¡AÃÓµú¸Öĵ§iºÙ¡A¹L§Ö©ñ¼e¤½¦@½Ã¥Í±¹¬I¡A«Ü¥i¯à·|¾É­P¬Ì±¡±²¤g­«¨Ó¡C¹w´ú¼Ò«¬Åã¥Ü¡A©Ò¦³©ñ¼e­­¨î±¹¬Iªº¬Ù¥÷¡A¯f¨Ò¿E¼Wªº±¡ªp³£¥i¯à·|¥X²{¡C

ÀHþÓ¹O¨Ó¹O¦hªº¬Ù¥÷±À¶i»P·s«a¯f¬r¦@¦sªº­p¹º¡A¹w´ú¼Ò«¬Åã¥Ü¡A·P¬VªÌ¯f¨Ò¼Æ¶q¥i¯à¬Æ¦Ü·|¶W¹L¤§«eªº®p­È¡A¤£¹L¦í°|¤H¼Æ¤´±N§C©ó«e¤@ªi¡C

¡u¦n®ø®§¬O¡A¥[®³¤j¤H¥Ø«eªº§K¬Ì¤ô¥­¹w­p±N´î¤Ö¥¼¨ÓOmicron·P¬Vªº¼vÅT¡CÀHþÓ°ª¤ô¥­ªº¬Ì­]±µºØ©M¯f¬r·P¬V¡A¹w­p·|¦³§ó¦hªº¤H¤fÀò±o¬Û·íªº§K¬Ì¤O¡A±q¦Ó­°§C¦í°|¤H¼Æ¡C¡v

³Ìªñ´X©P¡A¥[®³¤j¤H¤f³Ì¦hªº¨â­Ó¬Ù¥÷¦]·s«a¯f¬r¦Ó¦í°|ªº¤H¼Æ¦³©Ò¤U­°¡A³o¨Ï±o¨â¦aªº¬Ù©²¤U¨M¤ß³v¨B¨ú®ø¤½¦@½Ã¥Í±¹¬I¡C©P¤­¦w¬Ù¦í°|±wªÌ´î¤Ö61¤H¦Ü1281¤H¡C

¡u¹w­p¥u¦³¸û¤Öªº±wªÌ»Ý­n¦í°|¡A³o¼Ë¹ï§Ú­ÌÂåÀø«O°·¨t²Îªº¼vÅT´N¤£·|¨º»òÄY­«¡A§Y¨Ï¦³¤j¶q¯f¨Ò¡C¡v

¹w´ú¼Ò«¬ÁÙÅã¥Ü¡A¯f¬r·P¬VªÌ¬O§_±µºØ¹L¬Ì­]¡A¦b¤§«á·|§_µo®i¦¨¯e¯fªº­·ÀI¤W¡A¦³©úÅ㪺®t²§¡A¤×¨ä¬O50·³¤Î¥H¤W¦~ÄÖ²Õªº¤H¡A§ó»Ý­n¥[±j°w¡A¦]¬°¥L­Ì·P¬V¯f¬r«áµo®i¦¨­«¯gªº­·ÀI§ó°ª¡C

¡uÀHþӧڭ̨«¥X¦M¾÷¶¥¬q¡A§Ú­Ì²{¦b¥i¥HÄ~Äò¨Ì¾aÃöÁä¤u¨ã¶i¦æ¹w¨¾¡B¦­´Áµo²{©MÀ³¹ï¡A¥]¬A¬Ì­]¡BÀË´ú¡B±j¦³¤OªººÊ´ú¡B¤½¦@½Ã¥Í¥H¤ÎÂåÀø«O°·¡C¡v

¦b¥[°ê²Ä¤@ºØ¥H³J¥Õ½è¬°°ò¦ªº¿Õ¥Ë¥Ë§J´µ(Novavax)·s«a¬Ì­]NuvaxocidÀò­ã¨Ï¥Î«á¡A¦³±M®a§Æ±æ³o´Ú«DmRNA¬Ì­]¯à¥O§ó¦h¶¤±µºØ¬Ì­]µS¿Ý¤£©wªº¤H§ïÅÜ¥D·N¡C¹ï¦¹ÃÓµú¸ÖÂå¥Íªí¥Ü¡A¬O§_±Ä¥ÎNuvaxocid­n¬Ý¦U¬Ù¬F©²¨Ó¨M©w¡A¦P®É¥þ°ê½d³òªº¥Á·N½Õ¬dÅã¥Ü¡A¨º¨Ç³s¤@¾¯¬Ì­]³£ÁÙ¨S¥´ªº¤H¡A¤j¬ù¦³10%¦Ü50%ªí¥Ü¹ï³Ì·s³o´Ú¬Ì­]¦³¿³½ì¡C

§ó¦h­n»D¤@
Áp¨¹¨ú®øµn¾÷«ePCR³±©ÊÃÒ©ú
¡i©ú³ø±M°T¡jÀHþÓÁp¨¹¬F©²±q2¤ë28¤é°_¨ú®øµn¾÷«e¥X¥Ü®Ö»ÄÀË´ú(PCR)³±©ÊÃÒ©ú³W©w¡M®È¹C·~ªí¥Ü³Ìªñ®È¦æ¹w­q·~°È¥X²{¤«¼Q¦¡¼Wªø¡A3¤ë®ü¥~¾÷²¼­q... ¸Ô±¡
§I²{Äv¿ï©Ó¿Õ «P¶i°Ó·~Ácºa
¡i©ú³ø±M°T¡j¦w¬Ù¬ÙªøºÖ¯S¬Q¤Ñ(18¤é)«Å¥¬¡A¥Ñ4¤ë5¤é°_¥Ã¤[¨ú®ø¦¬¨ú§ùÄõ°Ï¹Ò¤º412©M418¨â±ø¤½¸ôªº¸ô¶O¡C¥L»¡¡A³o¬O§I²{¥t¤@¶µªºÄv¿ï©Ó¿Õ¡M... ¸Ô±¡
¨k¤l¦B³ý¹Ü»É¦Ê¦Ì³t·ÆºK»È
¡i©ú³ø±M°T¡j¥_¨Ê¥V¶ø·|¶i¤J²Ä14¤Ñ¡A¥[®³¤j©P¤­¼W²K2»È2»É4ªT¼úµP¡A¥O¥»°ê¼úµPÁ`¼Æ¼W¦Ü24ªT¡C ¥[®³¤j¿ï¤â®L´¶¡]Cassie Shar... ¸Ô±¡
¦h­Û¦h¬f¤å¥«³õ¨Ñ¤£À³¨D Ãþ¦ü³æ¦ì´X¤Ñº¦»ù¼Æ¸U¤¸
¡i©ú³ø±M°T¡j¦h­Û¦hªº¬f¤å¥«³õ¤õ¼ö¡A»ù®æ¨C©P³£¦b¼Wªø¡A¶R®a¹O¨Ó¹OÃø¥H©Ó¾á¡C Condos.caªºAndrew Harrildªí¥Ü¡A¬f¤å¸ê... ¸Ô±¡
¥«Ä³·|§å­ã¤µ¦~¹wºâ®×
¡i©ú³ø±M°T¡j¦h­Û¦h¥«Ä³·|§å­ã¤F2022¦~ªº¹wºâ®×¡C¦]¬Ì±¡¾É­Pªº14»õ¤¸ªº¯Ê¤f¥i¯à³Q­¢¨ú®ø«Ü¦h­p¹º¤¤ªºÀu¥ý¶µ¥Ø©Mºû«ù¥¿±`¹BÂ઺ºû­×¤u§@¡A¥«ªø²ø... ¸Ô±¡

©ú³øºô¯¸ ¡P ª©Åv©Ò¦³ ¡P ¤£±oÂà¸ü
Copyright © 2022 mingpaocanada.com All rights reserved.
Ming Pao Daily News A wholly owned subsidiary of Ming Pao Enterprise Corporation Ltd.
Toronto Chinese Newspaper

Chief Executive Officer: Ka Ming Lui | Executive Chief Editor: Richard Kwok Kai Ng
1355 Huntingwood Drive, Scarborough, Ontario, Canada M1S 3J1 | Tel.: (416) 321-0088 | Fax: (416) 321-5377 | Advertising Hotline Tel: (416) 673-8250